Financial Statements — CHSN
Balance Sheet
(in millions USD)| Metric | Q2
2025 | Q2
2024 | Q2
2023 |
|---|
| Cash & Equivalents | 22.09 | 4.11 | 1.47 |
| Accounts Receivable | 2.41 | 2.02 | 1.94 |
| Inventory | 0.71 | 0.79 | 0.58 |
| Total Current Assets | 27.47 | 13.20 | 7.06 |
| Property, Plant & Equipment | 5.32 | 5.01 | 5.48 |
| Intangible Assets | 0.24 | 0.14 | -- |
| Total Non-current Assets | 24.09 | 25.52 | 29.50 |
| Total Assets | 51.56 | 38.72 | 36.55 |
| Accounts Payable | 2.44 | 2.12 | 1.56 |
| Short-term Debt | 0.42 | 3.09 | 0.41 |
| Total Current Liabilities | 13.73 | 15.74 | 12.46 |
| Long-term Debt | 4.46 | -- | 2.00 |
| Total Non-current Liabilities | 13.29 | 10.93 | 11.97 |
| Total Liabilities | 27.02 | 26.67 | 24.43 |
| Retained Earnings | (0.66) | (0.13) | 0.10 |
| Total Stockholder Equity | 24.54 | 12.05 | 12.13 |
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2025 | Q2
2024 | Q2
2023 |
|---|
| Total Revenue | 8.69 | 7.54 | 8.81 |
| Cost of Revenue | 4.82 | 4.42 | 4.48 |
| Gross Profit | 3.87 | 3.13 | 4.33 |
| Selling, General & Admin | 2.24 | 1.46 | 1.77 |
| Total Operating Expenses | 5.06 | 3.69 | 4.22 |
| Operating Income | (1.19) | (0.56) | 0.11 |
| Interest Expense | -- | -- | (0.01) |
| Pretax Income | (0.99) | 0.09 | 0.29 |
| Tax Provision | 0.06 | 0.06 | 0.00 |
| Net Income | (1.05) | 0.02 | 0.28 |
| Basic EPS | (2.87) | 0.00 | 0.03 |
| Diluted EPS | (2.87) | 0.00 | 0.03 |
Cash Flow Statement
(in millions USD)| Metric | Q2
2025 | Q2
2024 | Q2
2023 |
|---|
| Operating Cash Flow | (0.39) | 0.81 | 0.61 |
| Capital Expenditures | -- | 0.03 | 0.15 |
| Free Cash Flow* | -- | 0.77 | 0.46 |
| Investing Cash Flow | 1.55 | 1.40 | (11.25) |
| Financing Cash Flow | 8.58 | 0.37 | 9.66 |
* Derived from reported values